Different approaches for determination of the attachment degree of polyethylene glycols to poly(anhydride) nanoparticles

Drug Development and Industrial Pharmacy

Volumn 36, Issue 6, 2010, Pages 676-680

  Yoncheva, K ^a   Doytchinova, I ^a   Irache, J M ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Colorimetry; Elemental analysis; Nuclear magnetic resonance; Pegylated nanoparticles; Polyethylene glycol

Indexed keywords

MACROGOL; NANOPARTICLE; POLYANHYDRIDE;

ANEMOMETRY; ARTICLE; CHEMICAL ANALYSIS; COLORIMETRY; DRUG DETERMINATION; PHOTON CORRELATION SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; TECHNIQUE; ZETA POTENTIAL;

BINDING SITES; DRUG DELIVERY SYSTEMS; NANOPARTICLES; POLYANHYDRIDES; POLYETHYLENE GLYCOLS;

EID: 77952508814     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639040903443434     Document Type: Article

References (13)

1. Stolnik S, Davies MC, Illum L, Davis SS, Boustta M, Vert M. (1994). The preparation of sub-200 nm colloidal particles from poly (malic acid-co-benzoyl malate) copolymers and their surface modification with poloxamer and poloxamine surfactants. J Control Release, 30:57-67.
2. Gref R, Domb A, Quellec P, Blunk T, Muller RH, Verbavatz JM, et al. (1995). The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev, 16:215-33.
3. Owens D, Peppas N. (2006). Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm, 307:93-102.
4. Yoncheva K, Gomez S, Campanero MA, Gamazo C, Irache JM. (2005). Bioadhesive properties of pegylated nanoparticles. Expert Opin Drug Deliv, 2:205-18.
5. Tobio M, Gref R, Sanchez A, Langer R, Alonso MJ. (1998). Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm Res, 15:270-5.
6. Yoncheva K, Lizarraga E, Irache JM. (2005). Pegylated nanoparticles based on poly (methyl vinyl ether-co-maleic anhydride): Preparation and evaluation of their bioadhesive properties. Eur J Pharm Sci, 24:411-9.
7. Yoncheva K, Guembe L, Campanero MA, Irache JM. (2007). Evaluation of bioadhesive potential and intestinal transport of pegylated poly (anhydride) nanoparticles. Int J Pharm, 334:156-65.
8. Storm G, Belliot SO, Daemen T, Lasic DD. (1995). Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliv Rev, 17:31-48.
9. Pompe T, Zschoche S, Herold N, Salchert K, Gouzy MF, Sperling C, et al. (2003). Maleic anhydride copolymers-a versatile platform for molecular biosurface engineering. Biomacromolecules, 4:1072-9.
10. Sims GEC, Snape TJ. (1980). A method for the estimation of polyethylene glycol in plasma protein fractions. Anal Biochem, 107:60-3.
11. Bazile D, Prud'homme C, Bassoullet M, Marlard M, Spenlehauer G, Veillard M. (1995). Stealth Me. PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J Pharm Sci, 84:493-8.
12. Olivier JC, Huertas R, Lee HJ, Calon F, Pardridge WM. (2002). Synthesis of pegylated immunonanoparticles. Pharm Res, 19:1137-43.
13. Dong Y, Feng SS. (2004). Methoxy poly (ethylene glycol) - poly (lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials, 25:2843-9.